TOP STORIES

• REGULATORY Chuikyo Subcommittee Effectively Kicks Off Debates on FY2018 Reform, with Focus on Pricy Meds
  August 25, 2016

• REGULATORY After Taltz Given High Price, MHLW to Push Use of Other Psoriasis Drugs; Revision to Foreign Price Adjustment Eyed
  August 25, 2016

• REGULATORY Chuikyo OKs Praluent, 8 Other APIs for Listing on Aug. 31
  August 24, 2016

• BUSINESS Sizzling DOAC Market - 1: Japan Sales Reaching 140 Billion Yen on 4-Way Fight
  August 24, 2016

• REGULATORY MHLW to Seek Funding to Promote and Support Healthcare Startups in FY2017 Budget Request
  August 23, 2016

• REGULATORY MHLW Set to Defend “High-Level Investment” Credits for Key R&D Tax Break System in FY2017 Reform
  August 22, 2016

• BUSINESS Evidence for Actair Sublingual Tablets “Sets It Apart from Other Therapies”: Shionogi
  August 22, 2016

• BUSINESS Amgen Confident of Getting Handsome Slice of Japan Biosimilar Market: Exec
  August 19, 2016

• INTERVIEW Interview: Ex-Astellas Boss Takenaka Urges Mid-Size Makers to Be More Open to Academia in Pathological Research
  August 18, 2016

• REGULATORY AMED Taking Steps toward “Aggressive Intellectual Property Management”: IP Department Head
  August 18, 2016

• BUSINESS CEO of Teva-Takeda JV Confident on Handling Both Long-Listed Brands, Generics
  August 17, 2016

• BUSINESS Mitsubishi Tanabe to Focus on Sales Turnaround for Canaglu, Eyes Diabetes and Nephrology Sales of 100 Bil. Yen
  August 17, 2016

• REGULATORY MHLW OKs First Generics for Tracleer, 6 Other APIs towards December Listing
  August 16, 2016

• BUSINESS Teijin Gets Japan Rights to Versartis’ Growth Hormone Deficiency Treatment
  August 15, 2016

• REGULATORY MHLW Study Group to Look at Measures to Popularize Biosimilars, Increase Efficiency in Development and Manufacturing
  August 12, 2016

• REGULATORY Startup Promotion Guide to Support Major Companies as well: MHLW Official
  August 10, 2016

• REGULATORY JMA, MHLW Say Possible Opdivo Re-Pricing Is Emergency Step, Won’t Make It Slippery Slope to Annual Revisions
  August 9, 2016

• ORGANIZATION EFPIA Japan Calls for Relaxation of Japanese Vaccine Regulations: Vaccine Subcommittee Head
  August 9, 2016

• REGULATORY MHLW Panel OKs Opdivo for RCC, ASKA’s Hepatic Encephalopathy Drug
  August 8, 2016

• INTERVIEW Japan Biosimilar Association Aims to Share Knowledge and Experience to Popularize the Use of Biosimilars: Director General
  August 5, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 145
• 146
• 147
• 148
• 149
• 150
• 151
• 152
• 153
• …
• Next ›
• 最終 »